Literature DB >> 26427444

Exercise and Cyclic Light Preconditioning Protect Against Light-Induced Retinal Degeneration and Evoke Similar Gene Expression Patterns.

Micah A Chrenek1, Jana T Sellers2, Eric C Lawson3,4, Priscila P Cunha5, Jessica L Johnson6, Preston E Girardot7, Cristina Kendall8, Moon K Han9,10, Adam Hanif11,12, Vincent T Ciavatta13,14, Marissa A Gogniat15,16, John M Nickerson17, Machelle T Pardue18,19, Jeffrey H Boatright20,21.   

Abstract

To compare patterns of gene expression following preconditioning cyclic light rearing versus preconditioning aerobic exercise. BALB/C mice were preconditioned either by rearing in 800 lx 12:12 h cyclic light for 8 days or by running on treadmills for 9 days, exposed to toxic levels of light to cause light-induced retinal degeneration (LIRD), then sacrificed and retinal tissue harvested. Subsets of mice were maintained for an additional 2 weeks and for assessment of retinal function by electroretinogram (ERG). Both preconditioning protocols partially but significantly preserved retinal function and morphology and induced similar leukemia inhibitory factor (LIF) gene expression pattern. The data demonstrate that exercise preconditioning and cyclic light preconditioning protect photoreceptors against LIRD and evoke a similar pattern of retinal LIF gene expression. It may be that similar stress response pathways mediate the protection provided by the two preconditioning modalities.

Entities:  

Keywords:  Aerobic exercise; Cyclic light rearing; Light-induced retinal degeneration; Preconditioning; Retinal degeneration

Mesh:

Substances:

Year:  2016        PMID: 26427444      PMCID: PMC5484395          DOI: 10.1007/978-3-319-17121-0_59

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  22 in total

1.  Protection of photoreceptor cells in adult rats from light-induced degeneration by adaptation to bright cyclic light.

Authors:  F Li; W Cao; R E Anderson
Journal:  Exp Eye Res       Date:  2001-10       Impact factor: 3.467

2.  Constitutive nitric oxide synthase activity is required to trigger ischemic tolerance in mouse retina.

Authors:  Yanli Zhu; Kevin K Ohlemiller; Belinda K McMahan; Tae Sung Park; Jeffrey M Gidday
Journal:  Exp Eye Res       Date:  2005-07-20       Impact factor: 3.467

3.  Ischemic preconditioning in the rat brain enhances the repair of endogenous oxidative DNA damage by activating the base-excision repair pathway.

Authors:  Wenjin Li; Yumin Luo; Feng Zhang; Armando P Signore; Glenn T Gobbel; Roger P Simon; Jun Chen
Journal:  J Cereb Blood Flow Metab       Date:  2006-02       Impact factor: 6.200

4.  Glaucoma-induced degeneration of retinal ganglion cells prevented by hypoxic preconditioning: a model of glaucoma tolerance.

Authors:  Yanli Zhu; Lihong Zhang; Jimena F Schmidt; Jeffrey M Gidday
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

Review 5.  Hypoxic preconditioning and erythropoietin protect retinal neurons from degeneration.

Authors:  Christian Grimm; A Wenzel; N Acar; S Keller; M Seeliger; Max Gassmann
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

Review 6.  Poised for success: implementation of sound conditioning strategies to promote endogenous protective responses to stroke in patients.

Authors:  Bethann McLaughlin; Jeff M Gidday
Journal:  Transl Stroke Res       Date:  2013-01-11       Impact factor: 6.829

7.  Deferroxamine preconditioning promotes long-lasting retinal ischemic tolerance.

Authors:  Yanli Zhu; Lihong Zhang; Jeffrey M Gidday
Journal:  J Ocul Pharmacol Ther       Date:  2008-12       Impact factor: 2.671

8.  Preconditioning-induced protection from oxidative injury is mediated by leukemia inhibitory factor receptor (LIFR) and its ligands in the retina.

Authors:  Srinivas Chollangi; Jiangang Wang; Aaron Martin; John Quinn; John D Ash
Journal:  Neurobiol Dis       Date:  2009-04-01       Impact factor: 5.996

9.  Retinal neuroprotection by hypoxic preconditioning is independent of hypoxia-inducible factor-1 alpha expression in photoreceptors.

Authors:  Markus Thiersch; Christina Lange; Sandrine Joly; Severin Heynen; Yun Zheng Le; Marijana Samardzija; Christian Grimm
Journal:  Eur J Neurosci       Date:  2009-06-08       Impact factor: 3.386

10.  Constitutive overexpression of human erythropoietin protects the mouse retina against induced but not inherited retinal degeneration.

Authors:  Christian Grimm; Andreas Wenzel; Dinu Stanescu; Marijana Samardzija; Svenja Hotop; Mathias Groszer; Muna Naash; Max Gassmann; Charlotte Remé
Journal:  J Neurosci       Date:  2004-06-23       Impact factor: 6.167

View more
  5 in total

1.  Adaptive Plasticity in the Retina: Protection Against Acute Injury and Neurodegenerative Disease by Conditioning Stimuli.

Authors:  Jeffrey M Gidday
Journal:  Cond Med       Date:  2018-02-15

Review 2.  Neuroprotective strategies for retinal disease.

Authors:  Machelle T Pardue; Rachael S Allen
Journal:  Prog Retin Eye Res       Date:  2018-02-23       Impact factor: 21.198

3.  Initial Assessment of Lactate as Mediator of Exercise-Induced Retinal Protection.

Authors:  Jana T Sellers; Micah A Chrenek; Preston E Girardot; John M Nickerson; Machelle T Pardue; Jeffrey H Boatright
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

4.  Low-Intensity Exercise in Mice Is Sufficient to Protect Retinal Function During Light-Induced Retinal Degeneration.

Authors:  Lukas M Mees; Monica M Coulter; Micah A Chrenek; Cara T Motz; Erica G Landis; Jeffrey H Boatright; Machelle T Pardue
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-04-01       Impact factor: 4.799

5.  Wheel running exercise protects against retinal degeneration in the I307N rhodopsin mouse model of inducible autosomal dominant retinitis pigmentosa.

Authors:  Xian Zhang; Preston E Girardot; Jana T Sellers; Ying Li; Jiaxing Wang; Micah A Chrenek; Wenfei Wu; Henry Skelton; John M Nickerson; Machelle T Pardue; Jeffrey H Boatright
Journal:  Mol Vis       Date:  2019-08-21       Impact factor: 2.367

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.